Search Results - "Weinkle, Susan H"

Refine Results
  1. 1

    Injection techniques for midface volumization using soft tissue hyaluronic acid fillers designed for dynamic facial movement by Galadari, Hassan, Weinkle, Susan H.

    Published in Journal of cosmetic dermatology (01-03-2022)
    “…Volume loss of the face occurs over time; thus, volume enhancement of the midface can counteract the effects of aging. Hyaluronic acid (HA) fillers are often…”
    Get full text
    Journal Article
  2. 2

    A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 Study by Green, Jeremy B., Mariwalla, Kavita, Coleman, Kyle, Ablon, Glynis, Weinkle, Susan H., Gallagher, Conor J., Vitarella, Domenico, Rubio, Roman G.

    Published in Dermatologic surgery (01-01-2021)
    “…BACKGROUNDSAKURA 3 was a Phase 3, open-label, repeat-dose safety study of DaxibotulinumtoxinA for Injection (DAXI); a component of the largest Phase 3 clinical…”
    Get full text
    Journal Article
  3. 3

    Effects of a Facial Cream Containing the Minor Alkaloid Anatabine on Improving the Appearance of the Skin in Mild to Moderate Rosacea: An Open-Label Case Series Study by Lanier, Ryan K., Cohen, Amy E., Weinkle, Susan H.

    Published in Case reports in dermatology (23-11-2013)
    “…Background: Current medical and scientific research indicates that rosacea, a chronic and often debilitating skin condition that primarily affects the central…”
    Get full text
    Journal Article
  4. 4

    Efficacy and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Glabellar Lines by Age and Race: Subgroup Analysis of the SAKURA Clinical Trials by Solish, Nowell, Burgess, Cheryl M, Weinkle, Susan H, Ablon, Glynis, Brown, Jessica, Kooken, Kristie, Rubio, Roman G

    Published in Aesthetic surgery journal (03-02-2023)
    “…DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A formulation approved for the treatment of glabellar lines. The efficacy, safety, and…”
    Get full text
    Journal Article
  5. 5

    Aesthetic Treatment Positively Impacts Social Perception: Analysis of Subjects From the HARMONY Study by Dayan, Steven, Rivkin, Alexander, Sykes, Jonathan M, Teller, Craig F, Weinkle, Susan H, Shumate, Garrett T, Gallagher, Conor J

    Published in Aesthetic surgery journal (13-11-2019)
    “…Abstract Background The impact of facial aesthetic treatments not only enhances physical appearance but also psychological well-being. Accordingly,…”
    Get full text
    Journal Article
  6. 6

    Multimodal Facial Aesthetic Treatment on the Appearance of Aging, Social Confidence, and Psychological Well-being: HARMONY Study by Cohen, Joel L, Rivkin, Alexander, Dayan, Steven, Shamban, Ava, Werschler, W Philip, Teller, Craig F, Kaminer, Michael S, Sykes, Jonathan M, Weinkle, Susan H, Garcia, Julie K

    Published in Aesthetic surgery journal (12-01-2022)
    “…Abstract Background A global approach to facial rejuvenation involves multiple treatment modalities. Objectives The aim of this study was to evaluate the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population by Cook-Bolden, Fran E., Weinkle, Susan H., Guenin, Eric, Bhatt, Varsha

    Published in Journal of drugs in dermatology (01-01-2019)
    “…Background: Acne vulgaris (acne) is the most common dermatologic disease seen in a racially, geographically, politically, culturally, and socioeconomically…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Safety and Effectiveness of Repeat Treatment With VYC-15L for Lip and Perioral Enhancement: Results From a Prospective Multicenter Study by Rivkin, Alexander, Weinkle, Susan H, Hardas, Bhushan, Weiss, Robert A, Glaser, Dee Anna, Biesman, Brian S, Schumacher, Andrew, Murphy, Diane K

    Published in Aesthetic surgery journal (14-03-2019)
    “…Abstract Background VYC-15L (Juvéderm Volbella XC) is a nonanimal crosslinked hyaluronic acid (HA) gel with lidocaine. Objectives To evaluate safety and…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Expert Consensus on Absorbable Advanced Suspension Technology for Facial Tissue Repositioning and Volume Enhancement by Nestor, Mark S, Ablon, Glynis, Andriessen, Anneke, Few, Julius, Gold, Michael H, Goldberg, David J, Lorenc, Paul, Mandy, Stephen, Weinkle, Susan H

    Published in Journal of drugs in dermatology (01-07-2017)
    “…BACKGROUND: Signs of facial aging include wrinkles, loss of subcutaneous volume, decreased tone, texture, and sagging of the skin. The objective of this review…”
    Get more information
    Journal Article
  15. 15

    Expert Consensus on Achieving Optimal Outcomes With Absorbable Suspension Suture Technology for Tissue Repositioning and Facial Recontouring by Lorenc, Z Paul, Ablon, Glynis, Few, Julius, Gold, Michael H, Goldberg, David J, Mandy, Stephen, Nestor, Mark S, Weinkle, Susan H

    Published in Journal of drugs in dermatology (01-06-2018)
    “…A complete approach to facial rejuvenation includes restoration of the skin's surface, relaxation of muscles that contribute to hyperkinetic movement,…”
    Get more information
    Journal Article
  16. 16

    Expert Consensus on Cosmetic Outcomes After Treatment of Actinic Keratosis by Berman, Brian, Ablon, Glynis R, Bhatia, Neal D, Ceilley, Roger I, Goldberg, David J, Nestor, Mark S, Weinkle, Susan H

    Published in Journal of drugs in dermatology (01-03-2017)
    “…Dermatologists treat actinic keratosis (AK) primarily because these lesions have the potential to progress to invasive squamous cell carcinoma. Patients, on…”
    Get more information
    Journal Article
  17. 17

    A multi-center, double-blind, randomized controlled study of the safety and effectiveness of Juvéderm® injectable gel with and without lidocaine by Weinkle, Susan H, Bank, David E, Boyd, Charles M, Gold, Michael H, Thomas, Jane A, Murphy, Diane K

    Published in Journal of cosmetic dermatology (01-09-2009)
    “…Summary Introduction  Pain is a common patient complaint during dermal filler injections. The primary objective of this study was to compare a new formulation…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20